1.2SPNov 14, 2022
Improving ECG-based COVID-19 diagnosis and mortality predictions using pre-pandemic medical records at population-scaleWeijie Sun, Sunil Vasu Kalmady, Nariman Sepehrvand et al.
Pandemic outbreaks such as COVID-19 occur unexpectedly, and need immediate action due to their potential devastating consequences on global health. Point-of-care routine assessments such as electrocardiogram (ECG), can be used to develop prediction models for identifying individuals at risk. However, there is often too little clinically-annotated medical data, especially in early phases of a pandemic, to develop accurate prediction models. In such situations, historical pre-pandemic health records can be utilized to estimate a preliminary model, which can then be fine-tuned based on limited available pandemic data. This study shows this approach -- pre-train deep learning models with pre-pandemic data -- can work effectively, by demonstrating substantial performance improvement over three different COVID-19 related diagnostic and prognostic prediction tasks. Similar transfer learning strategies can be useful for developing timely artificial intelligence solutions in future pandemic outbreaks.
1.2SPOct 21, 2020
Multilabel 12-Lead Electrocardiogram Classification Using Gradient Boosting Tree EnsembleAlexander William Wong, Weijie Sun, Sunil Vasu Kalmady et al.
The 12-lead electrocardiogram (ECG) is a commonly used tool for detecting cardiac abnormalities such as atrial fibrillation, blocks, and irregular complexes. For the PhysioNet/CinC 2020 Challenge, we built an algorithm using gradient boosted tree ensembles fitted on morphology and signal processing features to classify ECG diagnosis. For each lead, we derive features from heart rate variability, PQRST template shape, and the full signal waveform. We join the features of all 12 leads to fit an ensemble of gradient boosting decision trees to predict probabilities of ECG instances belonging to each class. We train a phase one set of feature importance determining models to isolate the top 1,000 most important features to use in our phase two diagnosis prediction models. We use repeated random sub-sampling by splitting our dataset of 43,101 records into 100 independent runs of 85:15 training/validation splits for our internal evaluation results. Our methodology generates us an official phase validation set score of 0.476 and test set score of -0.080 under the team name, CVC, placing us 36 out of 41 in the rankings.